ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting From TSX Venture Exchange
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ:IPA) (TSXV:IPA) announces that it has applied and has received approval for a voluntary delisting of its common shares from the